SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Samana Capital, L.P., et al. – ‘SC 13G’ on 3/4/02 re: Synaptic Pharmaceutical Corp

On:  Monday, 3/4/02   ·   Accession #:  950172-2-433   ·   File #:  5-45417

Previous ‘SC 13G’:  None   ·   Next:  ‘SC 13G’ on 3/25/02   ·   Latest:  ‘SC 13G’ on 11/13/15

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/04/02  Samana Capital, L.P.              SC 13G                 1:16K  Synaptic Pharmaceutical Corp      Skadden Arps Sla… LLP/FA
          PBK Holdings, Inc.
          Philip B. Korsant
          Zam-BVF Investments, L.L.C.

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                      9±    37K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Item 1(a). Name of Issuer
"Item 1(b). Address of Issuer's Principal Executive Offices
"Item 2(a). Name of Person Filing
"Item 2(b). Address of Principal Business Office or, if None, Residence
"Item 2(c). Citizenship
"Item 2(d). Title of Class of Securities
"Item 2(e). CUSIP Number
"Item 4. Ownership
"Item 5. Ownership of Five Percent or Less of a Class
"Item 6. Ownership of More than Five Percent on Behalf of Another Person
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
"Item 8. Identification and Classification of Members of the Group
"Item 9. Notice of Dissolution of Group
"Item 10. Certification


SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Synaptic Pharmaceutical Corp. ----------------------------- (Name of Issuer) Common Stock ------------------------------ (Title of Class of Securities) 87156R 10 9 ----------------------------- (CUSIP Number) February 14, 2002 ----------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ X ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 12 ------------------------------------------------------------------------------ CUSIP No. 87156R 10 9 13G Page 2 of 12 ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS ZAM-BVF Investments, L.L.C. ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 1,107,015 EACH ------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON 0 WITH ------------------------------------------- (8) SHARED DISPOSITIVE POWER 1,107,015 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,107,015 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.2% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) OO ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ CUSIP No. 87156R 10 9 13G Page 3 of 12 ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Ziff Asset Management, L.P. ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 1,107,015 EACH ------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON 0 WITH ------------------------------------------- (8) SHARED DISPOSITIVE POWER 1,107,015 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,107,015 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.2% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) PN ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ CUSIP No. 87156R 10 9 13G Page 4 of 12 ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS PBK Holdings, Inc. ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 1,107,015 EACH ------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON 0 WITH ------------------------------------------- (8) SHARED DISPOSITIVE POWER 1,107,015 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,107,015 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.2% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) CO ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ CUSIP No. 87156R 10 9 13G Page 5 of 12 ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Philip B. Korsant ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States of America ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 1,107,015 EACH ------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON 0 WITH ------------------------------------------- (8) SHARED DISPOSITIVE POWER 1,107,015 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,107,015 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.2% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) IN ------------------------------------------------------------------------------ Item 1(a). Name of Issuer. Synaptic Pharmaceutical Corp. ("Synaptic") Item 1(b). Address of Issuer's Principal Executive Offices. 215 College Road Paramus, NJ 07652 Item 2(a). Name of Person Filing. This Schedule 13G is being filed on behalf of the following persons ("Reporting Persons")*: (i) ZAM-BVF Investments, L.L.C. ("ZAM-BVF") (ii) Ziff Asset Management, L.P. ("ZAM") (iii) PBK Holdings, Inc. ("PBK") (iv) Philip B. Korsant * Attached as Exhibit 1 is a copy of an agreement among the Reporting Persons filing (as specified hereinabove) that this Schedule 13G is being filed on behalf of each of them. Item 2(b). Address of Principal Business Office or, if None, Residence. ZAM-BVF Investments, L.L.C. --------------------------- 153 East 53rd Street - 43rd Floor New York, NY 10022 Ziff Asset Management, L.P. --------------------------- 283 Greenwich Avenue Greenwhich, CT 06830 PBK Holdings, Inc. ------------------ 283 Greenwich Avenue Greenwhich, CT 06830 Philip B. Korsant ----------------- 283 Greenwich Avenue Greenwhich, CT 06830 Item 2(c). Citizenship. See Item 4 of the attached cover pages. Page 6 of 12 Item 2(d). Title of Class of Securities. Common Stock. Item 2(e). CUSIP Number. 87156R 10 9 Item 3. Not applicable as this Schedule is filed pursuant to Rule 13d 1(c) Item 4. Ownership. (a) Amount beneficially owned: See Item 9 of the attached cover pages. (b) Percent of class: See Item 11 of the attached cover pages. (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: See Item 5 of the attached cover pages. (ii) Shared power to vote or direct the vote: See Item 6 of the attached cover pages. (iii) Sole power to dispose or to direct the disposition: See Item 7 of the attached cover pages. (iv) Shared power to dispose or to direct the disposition: See Item 8 of the attached cover pages. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Philip B. Korsant shares voting and dispositive power over the shares of Common Stock that he beneficially owns with ZAM, the owner of record of the shares of Common Stock issuable upon conversion of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock. PBK also shares voting and dispositive power over the shares of Common Stock that it beneficially owns with ZAM. ZAM-BVF also shares voting and dispositive power over the shares of Common Stock that it beneficially owns with ZAM. Page 7 of 12 Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 8 of 12 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 4, 2002 ZAM-BVF INVESTMENTS, L.L.C. By: Ziff Asset Management, L.P., its Member By: PBK Holdings, Inc., its general partner By: /s/ Timothy J. Mitchell ---------------------------- Name: Timothy J. Mitchell Title: Vice President ZIFF ASSET MANAGEMENT, L.P. By: PBK Holdings, Inc., its general partner By: /s/ Timothy J. Mitchell -------------------------------- Name: Timothy J. Mitchell Title: Vice President PBK HOLDINGS, INC. By: /s/ Timothy J. Mitchell ------------------------------------ Name: Timothy J. Mitchell Title: Vice President /s/ Philip B. Korsant ------------------------------------ Name: Philip B. Korsant Page 9 of 12 INDEX TO EXHIBITS Page ---- EXHIBIT A Agreement of Reporting Persons 11 EXHIBIT B Statement by Ziff Asset Management, L.P. 12 disclaiming beneficial ownership of shares held by BVF Investments, L.L.C. Page 10 of 12 EXHIBIT A The undersigned, ZAM-BVF Investments L.L.C., a Delaware limited liability company, Ziff Asset Management, L.P., a Delaware limited partnership, PBK Holdings, Inc., a Delaware corporation, and Philip B Korsant, hereby agree and acknowledge that the information required by this Schedule 13G, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any further amendments or supplements thereto shall also be filed on behalf of each of them. Dated: March 4, 2002 ZAM-BVF INVESTMENTS, L.L.C. By: Ziff Asset Management, L.P., its Member By: PBK Holdings, Inc., its general partner By: /s/ Timothy J. Mitchell -------------------------------- Name: Timothy J. Mitchell Title: Vice President ZIFF ASSET MANAGEMENT, L.P. By: PBK Holdings, Inc., its general partner By: /s/ Timothy J. Mitchell --------------------------------- Name: Timothy J. Mitchell Title: Vice President PBK HOLDINGS, INC. By: /s/ Timothy J. Mitchell ------------------------------------ Name: Timothy J. Mitchell Title: Vice President /s/ Philip B. Korsant -------------------------------- Name: Philip B. Korsant Page 11 of 12 EXHIBIT B Ziff Asset Management, L.P. ("ZAM"), a Delaware limited partnership, disclaims beneficial ownership of the shares of Common Stock of Synaptic Pharmaceutical Corp. beneficially owned by BVF Investments, L.L.C., a Delaware limited liability company, in which ZAM is the sole investor and majority owner, because ZAM has no control of the voting or disposition of the shares. ZIFF ASSET MANAGEMENT, L.P. By: PBK Holdings, Inc., its general partner By: /s/ Timothy J. Mitchell ------------------------------- Name: Timothy J. Mitchell Title: Vice President Page 12 of 12

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13G’ Filing    Date    Other Filings
Filed on:3/4/02
2/14/02SC 13G/A
 List all Filings 
Top
Filing Submission 0000950172-02-000433   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 11:19:02.1pm ET